Eagle Bay Advisors’s Guardant Health GH Stock Holding History

Eagle Bay Advisors’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-84	Closed	-$10K	–	1169
2021 Q3	$10K	Buy	84 +42	+100%	+$4.99K	0.01%	734
2021 Q2	$6K	Buy	+42	New	+$5.65K	﹤0.01%	729

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Eagle Bay Advisors's GH Position: Q4 2021 in Review

Eagle Bay Advisors sold out of Guardant Health (GH) in Q4 2021, closing a stake of 84 shares — an estimated $10K sold.

Eagle Bay Advisors first reported a position in GH in Q2 2021 and held it in 2 quarters. The position peaked at $10K in Q3 2021. 396 funds tracked by Wall St. Rank hold GH as of Q4 2021.

Eagle Bay Advisors reported no remaining Guardant Health position as of Q4 2021 after selling out during the quarter.
Eagle Bay Advisors sold 84 Guardant Health shares in Q4 2021, an estimated $10K.
Eagle Bay Advisors first reported a position in Guardant Health in Q2 2021 and held it in 2 quarters.
Eagle Bay Advisors's Guardant Health position peaked at $10K in Q3 2021.
396 funds tracked by Wall St. Rank held Guardant Health as of Q4 2021.

Based on Eagle Bay Advisors's 13F filing for Q4 2021, filed 21 Jan 2022.